Know Cancer

or
forgot password
  • cancer clinical trials in tennessee

  • Sorafenib Long Term Extension Program (STEP)

    Nashville, Tennessee 37203-1632
    Neoplasms
    Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors
    Vanderbilt-Ingram Cancer Center

    Trial Locations
    Vanderbilt-Ingram Cancer Center
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Breast Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Thompson Cancer Survival Center-Dowell Springs

    Trial Locations
    Thompson Cancer Survival Center-Dowell Springs
    Thompson Oncology Group-West
    Thompson Oncology Group-Blount
    The West Clinic
    Breast Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    St. Jude Children's Research Hospital

    Trial Locations
    St. Jude Children's Research Hospital
    Vanderbilt-Ingram Cancer Center
    Hepatic Veno-Occlusive Disease
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Blue Ridge Medical Specialists, PC

    Trial Locations
    Blue Ridge Medical Specialists, PC
    Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center
    Wellmont Holston Valley Hospital and Medical Center
    Thompson Cancer Survival Center
    U.T. Medical Center Cancer Institute
    Lung Cancer
    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
    Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma
    Vanderbilt-Ingram Cancer Ctr
    Nashville, Tennessee 37232
    High Risk Stage III Melanoma
    Improving Outcomes Assessment in Chronic GVHD
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Chronic Graft Versus Host Disease
    Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, T-Cell, Juvenile Myelomonocytic Leukemia Lymphoblastic, T-cell Lymphoblastic Lymphoma, Myelodysplastic Syndrome
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Holston Medical Group

    Trial Locations
    Holston Medical Group
    Kore Cv Research
    Venous Thrombosis
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    University of Tennessee - Memphis
    Memphis, Tennessee 38163
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
    Vanderbilt-Ingram Cancer Center
    Nashville, Tennessee 37232-6838
    Bladder Cancer
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    University of Tennessee Cancer Institute - Memphis

    Trial Locations
    University of Tennessee Cancer Institute - Memphis
    Vanderbilt-Ingram Cancer Center
    Tennessee Oncology, PLLC at Sarah Cannon Cancer Center
    Leukemia
    Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
    Vanderbilt-Ingram Cancer Center at Franklin

    Trial Locations
    Vanderbilt-Ingram Cancer Center at Franklin
    Vanderbilt-Ingram Cancer Center, One Hundred Oaks
    Breast Cancer
    Energy Balance Interventions for Colorectal Cancer Prevention
    Vanderbilt-Ingram Cancer Center - Cool Springs

    Trial Locations
    Vanderbilt-Ingram Cancer Center - Cool Springs
    Vanderbilt-Ingram Cancer Center at Franklin
    Colorectal Cancer, Obesity
    CAT-8015 in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
    Research Site
    Chattanooga, Tennessee
    Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma
    Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
    ARIAD Investigational Site #076
    Nashville, Tennessee 37203
    Chronic Myelogenous Leukemia, Hematologic Malignancies
    A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
    The Sarah Cannon Cancer Center
    Nashville, Tennessee 37203
    Refractory Solid Tumors, Lymphoma
    Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Refractory Solid Tumors, Leukemia
    A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
    St Jude Children's Research Hospital
    Memphis, Tennessee 38105
    Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone
    Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
    East Tennessee Children's Hospital

    Trial Locations
    East Tennessee Children's Hospital
    St. Jude Children's Research Hospital
    Kidney Cancer, Leukemia, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer
    Vanderbilt-Ingram Cancer Center at Franklin
    Nashville, Tennessee 37064
    Colorectal Cancer, Hereditary Nonpolyposis Colorectal Cancer, Precancerous Condition
    Study to Evaluate Exemestane With and Without SNDX-275 in Treatment of Postmenopausal Women With Advanced Breast Cancer
    Chattanooga Oncology Hematology Associates

    Trial Locations
    Chattanooga Oncology Hematology Associates
    Sarah Cannon Cancer Center
    Breast Cancer, Estrogen Receptor-Positive Breast Cancer, Breast Cancer, Estrogen Receptor-Positive, ER+ Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Wellmont Holston Valley Hospital and Medical Center

    Trial Locations
    Wellmont Holston Valley Hospital and Medical Center
    Thompson Cancer Survival Center
    University of Tennessee - Knoxville
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Evaluation of the Duration of Therapy for Thrombosis in Children
    Vanderbilt University
    Nashville, Tennessee 37232-6305
    Venous Thrombosis
    Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
    Family Cancer Center, PLLC

    Trial Locations
    Family Cancer Center, PLLC
    University of Tennessee Cancer Institute (UTC)
    Multiple Myeloma
    Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
    St. Jude Children's Research Hospital
    Memphis, Tennessee 38105-2794
    Severe Combined Immunodeficiency, Malignancy, Hematologic, Neuroblastoma, Neoplasm, Mucopolysaccharidosis I